Specialized Health Services

(DVA) DaVita Incorporated – Bull of the Day

We are upgrading our recommendation on DaVita, Inc. (DVA) to Outperform based on the company’s strong cash flows and strategic acquisitions. The new bundled ESRD payment system is also expected to be a long-term positive. The company’s third-quarter earnings slightly... 

25Jan2012 | | 0 comments | Continued

(DVA) DaVita Analyst Rating Steady at Neutral

We have reiterated our Neutral recommendation on DaVita Inc. (DVA) based on strong top-line growth in the third quarter of 2011, which was partially offset by higher operating expenses. The company reported third-quarter operating earnings of $1.45 per share, exceeding the Zacks... 

9Dec2011 | | 0 comments | Continued

(HGR) Hanger Orthopedic’s Third Quarter Mixed – View Lowered

Orthotic and prosthetic (O&P) company Hanger Orthopedic’s (HGR) third-quarter fiscal 2011 adjusted earnings of 46 cents a share beat the Zacks Consensus Estimate by a penny and surpassed the year-ago adjusted earnings of 37 cents. The adjusted earnings exclude the costs... 

4Nov2011 | | 0 comments | Continued

(HWAY) Gallup-Healthways Report Well-Being

Healthways (HWAY), the well-being enhancement company, and statistical research services provider Gallup recently announced the results of the monthly Gallup-Healthways Well-Being Index (“WBI”) for August 2011. The overarching WBI measure remained on the higher side at 66.1. The... 

20Sep2011 | | 0 comments | Continued

(BIOS) BioScrip Analyst Maintains Neutral Rating on Shares

We maintain our Neutral recommendation on BioScrip Inc. (BIOS) with a target price of $6.25. BioScrip reported a loss of 4 cents per share in the second quarter of fiscal 2011 compared with the year-ago quarter EPS of 6 cents. However, after deducting the impact of restructuring... 

16Aug2011 | | 0 comments | Continued

(FMS) Fresenius Medical Care Completes IDC Buy

Fresenius Medical Care (FMS), the largest provider of dialysis products and services on the planet, has wrapped up its acquisition of Euromedic International’s (“Euromedic”) dialysis service division International Dialysis Centers (“IDC”) for €485 million (roughly... 

5Jul2011 | | 0 comments | Continued

(FMS) Fresenius Medical Care Offers Tips for Summer

Fresenius Medical Care (FMS), the largest provider of dialysis products and services in the globe, recently offered advice to renal patients to monitor their fluid intake during the parched summer months. Further, the company offered tips to dialysis patients on how to satisfy... 

1Jul2011 | | 0 comments | Continued

(HGR) Hanger Orthopedic Adopts NextGen Healthcare Solutions

Leading orthotic and prosthetic (O&P) company Hanger Orthopedic (HGR) has partnered with NextGen Healthcare, the wholly-owned subsidiary of Quality Systems’ (QSII). Under the collaboration, Hanger will implement NextGen’s Ambulatory electronic health record (“EHR”)... 

16Jun2011 | | 0 comments | Continued

(HWAY) Healthways Announces Insurance Deal for Wisconsin Fitness Drive

Healthways (HWAY), the well-being enhancement company, recently announced a new agreement with WPS Health Insurance (a non-profit health insurer in Wisconsin), whereby over 38,000 Wisconsin residents will gain access to the well-known SilverSneakers Fitness Program. As of the... 

16Jun2011 | | 0 comments | Continued

(HGR) Hanger Orthopedic Analyst Maintains Outperform on Shares

We reaffirm our Outperform rating on orthotic and prosthetic (O&P) company Hanger Orthopedic (HGR)  as we remain upbeat about its business prospects. Earnings for first-quarter fiscal 2011 matched the Zacks Consensus Estimate while profit skyrocketed 55% year over year owing... 

5Jun2011 | | 0 comments | Continued

(DVA) DaVita Beats Earnings Estimates on Revenues

DaVita Inc. (DVA) reported first-quarter net operating income of $94.5 million, or 96 cents per share, exceeding the Zacks Consensus Estimate by a penny. However, DaVita lagged the earnings of $109.4 million or $1.04 per share in the comparable quarter of 2010. This was attributable... 

4May2011 | | 0 comments | Continued

(BIOS) BioScrip Pharmacy Accredited

BioScrip Inc. (BIOS), a health care-related company recently received accreditation for its specialty pharmacy and mail service pharmacy from Utilization Review Accreditation Commission (URAC), a Washington-based health care accrediting organization that establishes quality standards... 

12Apr2011 | | 0 comments | Continued

(HGR) Hanger Orthopedic Group – Bull of the Day

We upgrade our recommendation on Hanger Orthopedic Group (HGR) to Outperform based on our assessment of the company’s forecast-beating fourth-quarter fiscal 2010 results and increased visibility on its business prospects. Earnings for the quarter topped the Zacks Consensus... 

25Mar2011 | | 0 comments | Continued

(BIOS) BioScrip Analyst Reaffirms Shares at Neutral

We maintain our Neutral recommendation on BioScrip Inc. (BIOS) following its tepid third-quarter fiscal 2010 results. Earnings for the quarter trailed both the Zacks Consensus Estimate and the year-ago earnings. Profit plummeted 66% year over year, hit by higher costs and tax. On... 

27Dec2010 | | 0 comments | Continued

(HGR) Hanger Orthopedic Quarterly Earnings Beats – Profit Slides

Hanger Orthopedic (HGR) posted adjusted earnings per share of 37 cents for third quarter fiscal 2010, beating the Zacks Consensus Estimate of 35 cents and exceeding the year-ago earnings of 30 cents. The adjusted earnings exclude costs (of $8 million) associated with the relocation... 

3Nov2010 | | 0 comments | Continued

(DVA) DaVita Prices $775 Million in Senior Notes

Moving ahead with its debt restructuring activity, on Tuesday, DaVita Inc. (DVA) announced the pricing of $775 million principal amount of 6?% senior notes due 2018 and $775 million principal amount of 6?% senior notes due 2020 totaling $1.55 billion. The net proceeds from the... 

8Oct2010 | | 0 comments | Continued

(DVA) DaVita Plans $1.45 Billion Senior Notes

Moving ahead with its debt restructuring activity, on Friday DaVita Inc. (DVA) announced its plan to sell about $1.45 billion of its senior notes and utilize the net proceeds to redeem another set of outstanding senior security notes, whose principal amount is worth $1.55 billion.... 

5Oct2010 | | 0 comments | Continued

(HGR) Hanger Orthopedic – Bull of the Day

We reiterate our Outperform recommendation on Hanger Orthopedic (HGR). Earnings for the last quarter beat the Zacks Consensus Estimate by a penny. Top-line growth was fueled by healthy contributions from patient-care and distribution businesses and acquisitions. Hanger is the... 

4Aug2010 | | 0 comments | Continued

(FMS) Fresenius Medical Care Buys Asia Renal Care

Fresenius Medical Care (FMS) recently undertook a major expansion in dialysis services in the Asia-Pacific region by signing a sales and purchase agreement to acquire Asia Renal Care, a wholly owned subsidiary of Bumrungrad International, an associate company of Bumrungrad Hospital. If... 

25May2010 | | 0 comments | Continued

(HGR) Hanger Orthopedic Group Analyst Maintains Outperform

We reiterate our ‘Outperform’ rating on Hanger Orthopedic Group, Inc. (HGR) with a target price of $21 based on a P/E of 16.4x our fiscal 2010 EPS estimate of $1.28. The company’s results for the first quarter fiscal 2010 were outstanding with growth witnessed across all... 

24May2010 | | 0 comments | Continued

(HGR) Hanger Orthopedic Group Reports Earnings In Line With Expectations

Hanger Orthopedic Group, Inc. (HGR) reported first quarter fiscal 2010 earnings per share of 16 cents, in line with the Zacks Consensus Estimate and higher than the year-ago earnings of 14 cents. Sales Net sales for the first quarter increased 5.4% year over year to $178.3 million.... 

29Apr2010 | | 0 comments | Continued

(HGR) Hanger Orthopedic Group – Consensus Earnings Estimates Rise

Hanger Orthopedic Group, Inc. (HGR) saw revenue rise year over year in 2009 and projects further growth in 2010. Hanger is trading with a forward P/E of 14.7. Company Description Hanger Orthopedic Group operates 677 patient care centers specializing in orthotics and prosthetics... 

30Mar2010 | | 0 comments | Continued

(DVA) DaVita Shows Positive Earnings Surprises and Earnings Revisions

Last month, DaVita Inc. (DVA), a leading provider of dialysis services in the United States to patients suffering from chronic kidney failure (also known as end stage renal disease (ESRD), announced its financial results for the fourth quarter and fiscal year ended Dec 31, 2009.... 

12Mar2010 | | 0 comments | Continued

(BIOS) BioScrip’s Fourth Quarter Report Shows Revenue Slide

BioScrip Inc. (BIOS) reported fourth-quarter earnings of 99 cents per share Incorporatedluding the impact of items such as the reversal of deferred tax valuation allowance of $41.1 million, expenses of $1.8 million associated with the pending acquisition of Critical Homecare... 

4Mar2010 | | 0 comments | Continued

(HGR) Hanger Orthopedic Group Beats Consensus Estimates

Hanger Orthopedic Group, Inc. (HGR) reported fourth quarter and full fiscal 2009 results. For the fourth quarter, earnings per share were 37 cents, beating the Zacks Consensus Estimate of 36 cents and the year-ago earnings of 26 cents. For fiscal 2009, earnings per share were... 

17Feb2010 | | 0 comments | Continued

(ALLI) Allion Healthcare Beats Estimates by a Penny

Allion Healthcare (ALLI) reported third quarter earnings of 13 cents per share excluding expenses related to the merger with an affiliate of H.I.G. Capital, LLC, beating the Zacks Consensus Estimate by a penny. The company reported identical earnings in the year-ago quarter. Revenues... 

4Dec2009 | | 0 comments | Continued

(HLS) HealthSouth Corporation – Raises Earnings Guidance

HealthSouth Corp. (HLS) is producing strong results by growing its revenue and more effectively managing its costs. Company Description HealthSouth Corp. operates as an inpatient care provider in the United States, owning and operating inpatient rehab care centers and long-term... 

7Nov2009 | | 0 comments | Continued

(DVA) DaVita Tops Consensus Estimates

DaVita Inc. (DVA) reported third quarter net income of $110.9 million or $1.06 per share, which was better than the Zacks Consensus Estimate of 99 cents. The company earned $93.9 million or 89 cents in the comparable quarter of 2008. Revenues for the quarter came in at $1.57... 

4Nov2009 | | 0 comments | Continued

(BIOS) BioScrip Earnings Report Beats Forecasts in Q3

BioScrip, Inc. (BIOS) reported third-quarter earnings of 14 cents per share, beating the Zacks Consensus Estimate of 10 cents. The company reported earnings of 6 cents in the year-ago period. Although earnings were better than expected, revenues declined 7.2% to $333.5 million.... 

2Nov2009 | | 0 comments | Continued

(HGR) Hanger Orthopedic Group Beats Earnings Consensus

Hanger Orthopedic Group, Inc. (HGR) yesterday reported financial results for the third quarter of fiscal 2009 after market close. Earnings per share were 30 cents, beating the Zacks Consensus Estimate of 27 cents and the year-ago earnings of 23 cents. Sales Net sales for the... 

27Oct2009 | | 0 comments | Continued